Intercontinental Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Intercontinental Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jan 19, 2021	SELL	$493.32 - $643.92 $12,333 - $16,097	-25 Reduced 33.33%	50 $16,000
Q1 2020 Jan 19, 2021	BUY	$336.18 - $494.43 $13,783 - $20,271	41 Added 120.59%	75 $31,000
Q4 2019 Feb 07, 2020	SELL	$274.13 - $376.51 $4,386 - $6,024	-16 Reduced 32.0%	34 $13,000
Q2 2019 Aug 02, 2019	SELL	$299.6 - $414.82 $7,490 - $10,370	-25 Reduced 33.33%	50 $16,000
Q1 2019 May 08, 2019	SELL	$372.08 - $439.57 $4,837 - $5,714	-13 Reduced 14.77%	75 $31,000
Q4 2018 Jan 31, 2019	BUY	$335.82 - $403.04 $29,552 - $35,467	88 New	88 $33,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Intercontinental Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Intercontinental Wealth Advisors, LLC with notifications on news.